Retraction to: Cell Death Discovery https://doi.org/10.1038/s41420-022-01000-w, published online 20 April 2022
The Editor in Chief has retracted this article. Concerns were raised about the apparent overlap between the two middle panels in Fig. 5H (si-RNF-44-1) and insufficient information about size of tumours in Fig. 7a. The authors did not provide raw data or proof that an ethics approval had been obtained before the beginning of the study. Additionally, Shaohua Ge stated they were not aware of the contents of the article, nor the submission process, because the email address provided on submission was not their email address. The authors did not state explicitly whether they agree to this retraction.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Liu, X., Zhao, T., Yuan, Z. et al. Retraction Note: MIR600HG sponges miR-125a-5p to regulate glycometabolism and cisplatin resistance of oral squamous cell carcinoma cells via mediating RNF44. Cell Death Discov. 9, 422 (2023). https://doi.org/10.1038/s41420-023-01711-8
Published:
Version of record:
DOI: https://doi.org/10.1038/s41420-023-01711-8
